George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

Share Price Information for Inc&gwth Vct (IGV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 68.50
Ask: 71.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.38%)
Open: 70.00
High: 70.00
Low: 70.00
Prev. Close: 70.00
IGV Live PriceLast checked at -
The Income & Growth VCT is an Investment Trust

To provide an attractive return by maximising dividend distributions from the income and capital gains generated by investment in unquoted companies. This may include AIM companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offers for Subscription and Issue of Prospectus

5 Oct 2022 13:50

RNS Number : 9185B
Income & Growth VCT (The) PLC
05 October 2022
 

Mobeus Income & Growth VCT plc (LEI: 213800HKOSEVWS7YPH79)

Mobeus Income & Growth 2 VCT plc (LEI: 213800LY62XLI1B4VX35)

Mobeus Income & Growth 4 VCT plc (LEI: 213800IFNJ65R8AQW943)

The Income & Growth VCT plc (LEI: 213800FPC15FNM74YD92)

 

Offers for Subscription and Issue of Prospectus

This announcement is made jointly by Mobeus Income & Growth VCT plc (MIG), Mobeus Income & Growth 2 VCT plc (MIG 2), Mobeus Income & Growth 4 VCT plc (MIG 4) and The Income & Growth VCT plc (I&G) (together the Companies and each a Company), which are advised by Gresham House Asset Management Limited (Gresham House).

The boards of the Companies are pleased to announce the launch of offers for subscription to raise, in aggregate, up to £47 million, with over-allotment facilities to raise, in aggregate, up to a further £29 million (together the Offers and each an Offer). The amount each Company is seeking to raise is set out below:

 

MIG

MIG 2

MIG 4

I&G

Maximum amount to be raised (excluding the over-allotment facility)

£14 million

£8 million

£11 million

£14 million

Maximum amount to be raised (including the over-allotment facility)

£22 million

£16 million

£16 million

£22 million

Full details of the Offers are contained in the prospectus issued by the Companies today (Prospectus). The Offers will open for applications at 9.00 a.m. on 17 October 2022 and will close for Applications (unless fully subscribed earlier or otherwise at the discretion of the relevant Board) at 5.30 p.m. on 27 March 2023. If a board decides (in consultation with Gresham House) to utilise its Company's over-allotment facility, this will be advised through a RIS announcement.

Investors can select which of the Companies they wish to invest in. Investors can apply to invest equally in all of the Companies or different amounts in one or more of the Companies (subject to an Offer not having closed prior to the application form being processed). The amount subscribed under each Offer will be invested into new ordinary shares of 1p each in the relevant Company.

Applications under an Offer will be accepted on a 'first-come, first-served' basis, subject always to the discretion of the relevant Company's board of directors. For these purposes 'first-come, first-served' shall be assessed based on the date and time of receipt of a fully completed application, subject to receipt of application monies (in full) in cleared funds within five business days thereafter to retain the applicant's position of priority.

The Prospectus, which has been approved by the Financial Conduct Authority, will shortly be available for download from the Companies' websites at:

· MIG: www.migvct.co.uk

· MIG 2: www.mig2vct.co.uk

· MIG 4: www.mig4vct.co.uk

· I&G: www.theincomeandgrowthvct.co.uk

The Prospectus will also shortly be available for inspection at the National Storage Mechanism, which is located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Pursuant to an offers' agreement dated 5 October 2022 relating to the Offers between, among others, each Company and Gresham House, each Company will pay Gresham House a fee of an amount representing 3.0% of the Investment Amounts (as defined in the Prospectus) in respect of applications accepted under its Offer, less an amount equal to (i) 0.5% of the Investment Amounts in respect of investors who receive advice from a financial adviser other than in respect of a Professional Client (as defined in the Prospectus) investor (and the application forms are completed by the financial adviser on this basis), (ii) 0.5% of the Investment Amounts where initial commission is waived by intermediaries in respect of applications from 'execution only' investors and Professional Client investors, (iii) 0.5% of the Investment Amounts in respect of direct investors who are existing shareholders in one or more of the Companies and (iv) any further amounts by which Gresham House agrees (at its discretion, but subject to not reducing Offer Costs (as defined in the Prospectus) to nil) to reduce its fees in respect of such applications, such amount being inclusive of VAT.

 

As Gresham House is a related party of each Company under the Listing Rules of the Financial Conduct Authority, the payment of such fee by each Company to Gresham House is a transaction to which Listing Rule 11.1.10 applies.

 

For further information, please contact:

Gresham House Asset Management Limited

Company Secretary

Telephone: +44 (0)20 7382 0999

 

 

 

Please note that the Mobeus VCTs and Gresham House cannot give any financial, legal, tax or investment advice.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIBDBDGSSGDGDU
Date   Source Headline
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
29th Feb 20242:00 pmRNSResult of Annual General Meeting
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
27th Feb 20249:30 amRNSInterim Management Statement
1st Feb 202411:35 amRNSVoting Rights and Capital
22nd Jan 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20249:04 amRNSAnnual Financial Report
2nd Jan 20242:30 pmRNSVoting Rights and Capital
1st Dec 20237:00 amRNSTotal Voting Rights
8th Nov 202310:20 amRNSDirector/PDMR Shareholding
8th Nov 202310:15 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSTransaction in Own Shares
25th Sep 202311:00 amRNSDividend Declaration
20th Sep 20233:30 pmRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:02 pmRNSTransaction in Own Shares
14th Jun 20237:00 amRNSHalf-year Report
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20235:15 pmRNSDirector/PDMR Shareholding
26th May 20235:00 pmRNSIssue of Equity and Total Voting Rights
26th May 20234:36 pmRNSNet Asset Value(s)
2nd May 202310:00 amRNSTotal Voting Rights
13th Apr 20231:00 pmRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202311:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment:Tharstern Group Limited
3rd Mar 20235:04 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:30 pmRNSInterim Management Statement
22nd Feb 20233:15 pmRNSResult of AGM
7th Feb 20237:01 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:14 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:34 pmRNSTransaction in Own Shares
19th Dec 20227:00 amRNSAnnual Financial Report
13th Dec 20223:47 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.